Earnings Ahead

JNJ - Johnson

158.08 -0.55 -0.35

Johnson

Johnson

About

Profile

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.


Headquarters

New Brunswick, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

JNJ



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform
  • Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M
  • J&J looks to continue long streak of EPS beats with Q2 results
  • J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)
  • J&J becomes latest Big Pharma to sue over Medicare drug pricing
  • Nanobiotix partners with J&J's Janssen for radiotherapy treatment
  • Atrial fibrillation drug market expected to decline as brand therapies go generic
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
  • FDA classifies J&J electrode recall as most serious type
  • Goldman Sachs sees rays of hope in underperforming health sector
  • Bausch + Lomb buys Blink eye drops from Johnson & Johnson
  • Johnson & Johnson psoriasis pill disappoints in phase 2 trial
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Morgan Stanley shakes up its global dividend portfolio
  • J&J submits application to EMA for combination PAH drug
  • What is behind big pharma's underperformance?
  • J&J talc bankruptcy unit to establish $750M trust fund with insurers
  • Cidara gains as FDA grants fast track status for flu candidate
  • Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations

Earnings History

Date EPS / Forecast Revenue / Forecast
January 25, 2022 2.13 / 2.12 24.8B / 25.28B
October 19, 2021 2.6 / 2.35 23.34B / 23.64B
July 21, 2021 2.48 / 2.29 23.31B / 22.49B Beat!
April 20, 2021 2.59 / 2.34 22.32B / 21.98B Beat!
January 26, 2021 1.86 / 1.82 22.48B / 21.66B Beat!
October 13, 2020 2.2 / 1.98 21.08B / 20.2B Beat!
July 16, 2020 1.67 / 1.49 18.34B / 17.61B Beat!
April 14, 2020 2.3 / 2.02 20.69B / 19.73B Beat!
January 22, 2020 1.88 / 1.87 20.75B / 20.8B
October 15, 2019 2.12 / 2.01 20.73B / 20.08B Beat!
July 16, 2019 2.58 / 2.46 20.56B / 20.29B Beat!
April 16, 2019 2.1 / 2.04 20.02B / 19.61B Beat!
January 22, 2019 1.97 / 1.95 20.39B / 20.2B Beat!
October 16, 2018 2.05 / 2.03 20.35B / 20.05B Beat!
July 17, 2018 2.1 / 2.07 20.83B / 20.42B Beat!
April 17, 2018 2.06 / 2 20.01B / 19.49B Beat!
January 23, 2018 1.74 / 1.72 20.2B / 20,072M
October 17, 2017 1.9 / 1.80 19.65B / 19,283M
July 18, 2017 1.83 / 1.80 18.84B / 18,935M
April 18, 2017 1.83 / 1.77 17.77B / 18,037M
Date Price Open High Low Vol Change
Jan 23 146.64 145.44
147.9
144.95
9.9M 0.94%
Jan 22 145.27 144
145.47
142.11
16.8M -1.94%
Jan 21 148.15 147.56
148.86
147.05
11.1M 0.76%
Jan 17 147.03 147.44
148.38
146.61
10.8M -0.5%
Jan 16 147.77 144.32
148.07
144.06
9.0M 1.93%
 
Jan 15 144.97 145.31
146.05
144.26
7.4M 0.15%
Jan 14 144.75 144.5
144.81
142.86
8.7M 0.19%
Jan 13 144.47 142.98
145.07
142.31
10.4M 1.70%
Jan 10 142.06 141
143.67
140.68
8.8M -0.15%
Jan 8 142.27 145.49
145.59
141.44
11.2M -2.71%
Jan 7 146.23 143.76
147.18
143.59
8.4M 1.79%
Jan 6 143.66 143.51
144.82
142.93
7.9M -0.37%
Jan 3 144.19 144.07
144.57
143.62
5.9M 0.12%
Jan 2 144.02 145.23
145.77
143.78
6.1M -0.41%
Dec 31, 2024 144.62 143.76
144.67
143.31
5.8M 0.89%
Dec 30, 2024 143.34 144.84
144.88
142.95
6.3M -1.18%
Dec 27, 2024 145.05 144.87
146.6
144.68
5.6M -0.36%
Dec 26, 2024 145.58 145.51
146.37
145.09
4.7M -0.19%
Dec 24, 2024 145.85 145
145.85
144.33
3.2M 0.40%
Dec 23, 2024 145.27 144.63
145.33
143.45
8.7M 0.55%
Dec 20, 2024 144.47 143.05
145.47
142.75
17.7M 0.62%
Dec 19, 2024 143.58 144.14
145.22
143.37
9.5M -0.81%
Dec 18, 2024 144.75 145.68
146.74
144.67
9.3M -1.13%
Dec 17, 2024 146.41 143.84
146.66
143.71
10.3M 1.78%
Dec 16, 2024 143.85 146.73
147.25
143.52
8.7M -1.89%
Dec 13, 2024 146.62 145.66
146.93
145.04
8.3M 0.26%
Dec 12, 2024 146.24 147.2
147.77
146.01
6.2M -0.27%
Dec 11, 2024 146.64 148.5
148.5
146.37
13.4M -1.74%
Dec 10, 2024 149.23 149.93
150.83
148.33
9.4M -0.25%
Dec 9, 2024 149.6 149.29
150.89
148.44
8.4M 0.19%
Dec 6, 2024 149.31 149.39
150.05
148.38
8.4M -0.14%
Dec 5, 2024 149.52 150
150.38
148.95
7.9M -0.63%
Dec 4, 2024 150.47 151.29
151.56
149.75
10.3M -1.24%
Dec 3, 2024 152.36 154.8
154.8
152.3
8.7M -1.58%
Dec 2, 2024 154.8 154.75
155
153.93
6.9M -0.14%
Nov 29, 2024 155.01 154.89
155.67
154.17
5.7M -0.25%
Nov 27, 2024 155.4 154.63
156.63
154.6
4.1M 0.57%
Nov 26, 2024 154.52 155.16
155.25
153.16
5.7M -0.81%
Nov 25, 2024 155.78 155.17
157.04
155.14
12.3M 0.39%
Nov 22, 2024 155.17 155.9
157.12
154.11
8.3M -0.21%
Nov 21, 2024 155.5 153.62
156.06
152.81
10.1M 1.56%
Nov 20, 2024 153.11 153.03
153.25
151.81
9.1M 0.07%
Nov 19, 2024 153 153.95
153.99
152.05
8.2M -1.14%
Nov 18, 2024 154.77 152.59
155.33
152.33
7.5M 0.50%
Nov 15, 2024 154 150.9
154.43
150.9
11.3M 1.40%
Nov 14, 2024 151.87 153.18
153.59
150.76
7.7M -0.89%
Nov 13, 2024 153.24 152.5
153.51
151.42
7.2M 0.39%
Nov 12, 2024 152.64 154.53
155.04
152.37
7.2M -1.55%
Nov 11, 2024 155.04 155.62
157.58
154.91
7.1M -0.28%
Nov 8, 2024 155.47 157
157.08
155.41
8.9M -0.8%
Nov 7, 2024 156.73 158.47
158.75
156.51
7.5M -0.73%
Nov 6, 2024 157.88 159.9
160.85
157.35
8.9M -0.3%
Nov 5, 2024 158.35 157.67
158.59
156.35
6.5M 0.07%
Nov 4, 2024 158.24 159.7
160.28
158.07
4.6M -1.18%
Nov 1, 2024 160.13 160.58
161.06
159.88
5.3M 0.17%
Oct 31, 2024 159.86 159.99
160.87
159.46
8.6M -0.47%
Oct 30, 2024 160.61 159.45
161.28
159.03
5.8M 0.32%
Oct 29, 2024 160.09 161.46
162.17
160.06
5.2M -0.93%
Oct 28, 2024 161.6 161.13
161.97
161
4.8M 0.45%
Oct 25, 2024 160.88 163.68
163.92
160.61
6.4M 0%